The introduction of targeted therapy for the treatment of advanced renal cell carcinoma (RCC) has improved the outcome of these patients in the last decade. However, many patients still relapse. The aim of this consensus study was to establish common recommendations about the best treatment options...
If the results show that you have renal cell carcinoma, your doctor will find out what stage it’s in, so you can decide on the best treatment options. The stage of cancer depends on how large your tumor is and whether the cancer has spread to other parts of your body. You may have...
Renal Cell Carcinoma Abstract ImportanceRenal cell carcinoma (RCC) is a common malignancy, with an estimated 434 840 incident cases worldwide in 2022. In the US, it is the sixth most common cancer among males and ninth among females. ObservationsClear cell RCC is the most comm...
Sarcomatoid dedifferentiation is an uncommon feature that can occur in most histological subtypes of renal cell carcinomas (RCCs) and carries a decidedly poor prognosis. Historically, conventional treatments for sarcomatoid RCCs (sRCCs) have shown little efficacy, and median survival is commonly 6–13...
Renal cell carcinoma (RCC) is one of the most life-threatening urinary malignancies displaying poor response to radiotherapy and chemotherapy. Although in the recent past there have been tremendous
EP: 1.Renal Cell Carcinoma: Risk Stratification and Evolving Treatment Landscape EP: 2.Case 1: Therapeutic Sequencing for Relapsed/Refractory Metastatic Clear Cell RCC EP: 3.RCC: Treatment Goals in the Third-Line Setting EP: 4.TIVO-3: Tivozanib vs Sorafenib in Advanced Renal Cell Carcinoma EP...
At this year's ASCO Annual Meeting, researchers presented detailed findings concerning biomarkers and rare subtypes of renal cell carcinoma. Identifying aunique biomarker can be achallenging endeavor, but patients with metastatic RCC are living longer due to the availability of multiple therapeutic ...
Introduction: Pharmacotherapy for metastatic renal cell carcinoma (mRCC) has been revolutionized during the last years due to improved understanding of the molecular pathways that underlie tumor development and progression.Areas covered: This manuscript reviews all the approved drugs for the treatment of ...
ReviewRenal cell carcinoma (RCC) is the 10th leading cause of deaths from cancer in the Western world. During the last two decades this type of malignancy was difficult to treat with limited treatment options using cytokines like interferon alpha (IFN) or inte......
EP: 3.Clinical Trial Data Updates in Advanced Renal Cell Carcinoma EP: 4.Clear Cell RCC: Strategies for Selecting Appropriate Frontline Treatment EP: 5.Second-Line Treatment Options for Patients With Clear Cell RCC EP: 6.Strategies for Sequencing Therapies in Renal Cell Carcinoma ...